𝔖 Bobbio Scriptorium

✦ LIBER ✦

Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis

✍ Scribed by Dong, Shu; Su, Shi-bing

Book ID: 125825690
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 693 KB
Volume: 12
Category: Article
ISSN: 2095-4964
DOI: 10.1016/S2095-4964(14)60022-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Rougan Huaqian granules combin

Effect of Rougan Huaqian granules combined with human mesenchymal stem cell transplantation on liver fibrosis in cirrhosis rats

✍ Wang, Zhen-Chang; Yang, Shan; Huang, Jing-Jing; Chen, Song-Lin; Li, Quan-Qiang; 📂 Article 📅 2014 🏛 Medknow Publications 🌐 English ⚖ 343 KB

Intensive management for raising surviva

Intensive management for raising survival rate of small cell lung cancer (SCLC) with combined multi-therapy including traditional Chinese medicine

✍ Cha, R; Li, W; Zheng, L; Zeng, D; Li, Wei-Hua 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Chemotherapy in conjunction with traditi

Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial

✍ Zhou, Zhi-yi; Xu, Ling; Li, He-gen; Tian, Jian-hui; Jiao, Li-jing; You, Sheng-fu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 648 KB

306: Successful phase II trial using mes

306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

✍ P. Kebriaei; L. Isola; E. Bahceci; H.K. Holland; S. Rowley; J. McGuirk; M. Devet 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB